Interestingly, the interaction between ILF2 and ILF3 was promoted by overexpression of FTO-IT1, while inhibited by knockdown of FTO-IT1 in HCC cells (Fig. 4D and E). The gene discussed is ILF2; the disease is hepatocellular carcinoma.